Keywords: novartis, prexige, withdrawn, uk, german, austrian, regulators

Novartis' Prexige withdrawn by UK, German and Austrian regulators on liver safety fears

Article | 26 November 2007

Print This

Health regulators in the UK and Germany have suspended the marketing and sale of Novartis' Prexige (lumiracoxib), a COX-2 inhibitor ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in